ProThera Biologics Inc. Secures $500,000 New Funding

  • Feed Type
  • Date
    6/24/2008
  • Company Name
    ProThera Biologics Inc.
  • Mailing Address
    551 Warren Avenue East Providence, RI 02914
  • Company Description
    The mission of the company is to develop novel products that exploit the promise of personalized medicine by leveraging on its proprietary technology of natural serine protease inhibitor proteins.
    The company focuses on unmet medical needs by developing INTEGRATED theranostic and therapeutic biomolecules for serious human diseases such as sepsis and cancer.
  • Website
    http://www.protherabiologics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Richard Horan of the Slater Technology Fund said, “With additional investment and with Rick Andrews coming on-board, we are excited about the prospects of accelerating the company’s efforts in the development of what promise to be significant advances in clinical medicine.”
  • M&A Terms
  • Venture Investor
    Slater Technology Fund

By posting a comment, you agree to our terms and conditions.